DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Molecular Imaging Homepage

New PET imaging agent predicts tumor response to lung cancer drug Could lead to better patient management and outcomes

PET beats SPECT for detecting coronary artery disease: study Detected 79 percent of severe obstructive cases versus 70 percent

PET/MR and the future of pediatric chemotherapy Dr. Ashok Joseph Theruvath, postdoctoral research fellow in the Molecular Imaging Program at the Stanford School of Medicine discusses promising research for assessing pediatric chemo outcomes

Availity announces debut of pre-clearance service at HIMSS Confirms imaging authorization in minutes and ensures patient payments prior to visit

NTP Radioisotopes facility resumes production following hydrogen leak Produces Mo-99 for US, European and other global customers

NCCN adds Axumin to guidelines for prostate cancer treatment Enhances support for imaging agent from private payors

Lisa Hazen ARRT appoints new Nuclear Medicine Technology (NMT) Relationship Manager

SHINE completes Building One of medical isotope production facility Facility is projected to become domestic source for Mo-99 production in US

Ian Wilson ImaginAb appoints chief operating officer

Study finds patients lack info about imaging exams Researchers uncover what they want to know

The molecular structure of a
gold-based precursor used
for PET tracer synthesis,
determined by X-ray

Researchers discover mechanism to develop new PET radiotracers

by Lauren Dubinsky , Senior Reporter
New PET radiotracers may soon be coming down the pike, thanks to a chemical mechanism discovered by scientists at Berkeley Lab and UC Berkeley.

"Overall there are limited traditional organic chemistry mechanisms that are fast enough or scale well enough to allow efficient radiochemistry," James P. O'Neil, staff scientist and group leader at the Lawrence Berkeley National Laboratory, told HCB News.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

When studying chemical reactions of a gold-containing molecule, the research team stumbled upon a chemical mechanism that can be used to form trifluoromethyl (CF3) compounds and attach them to other chemical compounds.

This discovery could aid in the development of new classes of PET radiotracers that have previously been too difficult or even impossible to prepare.

"While substantial interest has been given lately to the trifluoromethyl group in the context of radiotracer development for PET, attempts to access this group by nucleophilic and electrophilic radio fluorination protocols date back to 1979," said O'Neil.

The new chemical mechanism that's based on the discovery in gold chemistry, allows the team to attach a radioactive fluorine atom to a specific class of molecule that was previously challenging to do.

Drug companies have been increasingly interested in incorporating CF3 compounds in a range of pharmaceuticals because it makes them more selective, effective or potent. The antidepressant Prozac, HIV drug Sistiva and anti-inflammatory Celebrex are a few drugs that contain CF3 compounds.

O'Neil noted that the pharmaceutical field and diagnostic medicine field have been very limited in getting compounds that have been labeled with radioactive CF3, but yet there are a lot of drugs that have CF3 in them.

The team hopes to partner with a group that has a specific biological target or drug candidate of interest that contains a CF3 compound to adapt the new mechanism to the specific application. They can then work on developing radiotracers that incorporate the compound.

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.